Famotidine, a histamine H2-receptor antagonist, is occasionally used off-label in cluster headache management, though its primary mechanism is not directly targeting headache pathophysiology. By competitively blocking H2 receptors in vascular smooth muscle and reducing gastric acid secretion, famotidine may indirectly contribute to modulating inflammatory responses and vascular tone that could potentially influence headache dynamics.